nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—DCK—hematologic cancer	0.144	1	CbGaD
Fludarabine—Clofarabine—hematologic cancer	0.091	0.302	CrCtD
Fludarabine—Nelarabine—hematologic cancer	0.0856	0.284	CrCtD
Fludarabine—Cytarabine—hematologic cancer	0.0631	0.209	CrCtD
Fludarabine—Cladribine—hematologic cancer	0.0615	0.204	CrCtD
Fludarabine—RRM1—Clofarabine—hematologic cancer	0.0277	0.11	CbGbCtD
Fludarabine—POLA1—Nelarabine—hematologic cancer	0.0262	0.104	CbGbCtD
Fludarabine—POLA1—Clofarabine—hematologic cancer	0.024	0.095	CbGbCtD
Fludarabine—RRM1—Hydroxyurea—hematologic cancer	0.0195	0.0774	CbGbCtD
Fludarabine—DCK—Nelarabine—hematologic cancer	0.0161	0.0639	CbGbCtD
Fludarabine—DCK—Clofarabine—hematologic cancer	0.0147	0.0585	CbGbCtD
Fludarabine—RRM1—Cladribine—hematologic cancer	0.0135	0.0537	CbGbCtD
Fludarabine—POLA1—Cytarabine—hematologic cancer	0.0124	0.0491	CbGbCtD
Fludarabine—POLA1—Cladribine—hematologic cancer	0.0117	0.0464	CbGbCtD
Fludarabine—SLC28A3—Cladribine—hematologic cancer	0.0117	0.0464	CbGbCtD
Fludarabine—SLC28A3—Mercaptopurine—hematologic cancer	0.0109	0.0431	CbGbCtD
Fludarabine—RRM1—Gemcitabine—hematologic cancer	0.00872	0.0346	CbGbCtD
Fludarabine—SLC29A1—Cytarabine—hematologic cancer	0.00823	0.0326	CbGbCtD
Fludarabine—DCK—Cytarabine—hematologic cancer	0.00763	0.0302	CbGbCtD
Fludarabine—POLA1—Gemcitabine—hematologic cancer	0.00754	0.0299	CbGbCtD
Fludarabine—SLC28A3—Gemcitabine—hematologic cancer	0.00754	0.0299	CbGbCtD
Fludarabine—SLC29A1—Mercaptopurine—hematologic cancer	0.00723	0.0286	CbGbCtD
Fludarabine—DCK—Cladribine—hematologic cancer	0.0072	0.0286	CbGbCtD
Fludarabine—Adenosine triphosphate—Nelarabine—hematologic cancer	0.0068	0.0331	CrCrCtD
Fludarabine—Ribavirin—Clofarabine—hematologic cancer	0.0067	0.0326	CrCrCtD
Fludarabine—Ribavirin—Nelarabine—hematologic cancer	0.0063	0.0306	CrCrCtD
Fludarabine—Regadenoson—Clofarabine—hematologic cancer	0.00625	0.0304	CrCrCtD
Fludarabine—S-Adenosylmethionine—Clofarabine—hematologic cancer	0.00625	0.0304	CrCrCtD
Fludarabine—Regadenoson—Nelarabine—hematologic cancer	0.00588	0.0286	CrCrCtD
Fludarabine—S-Adenosylmethionine—Nelarabine—hematologic cancer	0.00588	0.0286	CrCrCtD
Fludarabine—Clofarabine—Nelarabine—hematologic cancer	0.00588	0.0286	CrCrCtD
Fludarabine—Azacitidine—Pentostatin—hematologic cancer	0.00557	0.0271	CrCrCtD
Fludarabine—Cladribine—Pentostatin—hematologic cancer	0.00557	0.0271	CrCrCtD
Fludarabine—Vidarabine—Pentostatin—hematologic cancer	0.00557	0.0271	CrCrCtD
Fludarabine—Adenosine—Pentostatin—hematologic cancer	0.00557	0.0271	CrCrCtD
Fludarabine—Adenosine monophosphate—Clofarabine—hematologic cancer	0.00552	0.0269	CrCrCtD
Fludarabine—Nelarabine—Clofarabine—hematologic cancer	0.00552	0.0269	CrCrCtD
Fludarabine—Cytarabine—Clofarabine—hematologic cancer	0.00523	0.0254	CrCrCtD
Fludarabine—Adenosine monophosphate—Nelarabine—hematologic cancer	0.00519	0.0253	CrCrCtD
Fludarabine—SLC29A1—Gemcitabine—hematologic cancer	0.00501	0.0199	CbGbCtD
Fludarabine—Adenosine—Clofarabine—hematologic cancer	0.00496	0.0241	CrCrCtD
Fludarabine—Vidarabine—Clofarabine—hematologic cancer	0.00496	0.0241	CrCrCtD
Fludarabine—Cladribine—Clofarabine—hematologic cancer	0.00496	0.0241	CrCrCtD
Fludarabine—Azacitidine—Clofarabine—hematologic cancer	0.00496	0.0241	CrCrCtD
Fludarabine—Cytarabine—Nelarabine—hematologic cancer	0.00492	0.0239	CrCrCtD
Fludarabine—Vidarabine—Nelarabine—hematologic cancer	0.00467	0.0227	CrCrCtD
Fludarabine—Adenosine—Nelarabine—hematologic cancer	0.00467	0.0227	CrCrCtD
Fludarabine—Cladribine—Nelarabine—hematologic cancer	0.00467	0.0227	CrCrCtD
Fludarabine—Azacitidine—Nelarabine—hematologic cancer	0.00467	0.0227	CrCrCtD
Fludarabine—Ribavirin—Cytarabine—hematologic cancer	0.00464	0.0226	CrCrCtD
Fludarabine—DCK—Gemcitabine—hematologic cancer	0.00464	0.0184	CbGbCtD
Fludarabine—Clofarabine—Cytarabine—hematologic cancer	0.00433	0.0211	CrCrCtD
Fludarabine—Regadenoson—Cytarabine—hematologic cancer	0.00433	0.0211	CrCrCtD
Fludarabine—S-Adenosylmethionine—Cytarabine—hematologic cancer	0.00433	0.0211	CrCrCtD
Fludarabine—Clofarabine—Cladribine—hematologic cancer	0.00422	0.0205	CrCrCtD
Fludarabine—Regadenoson—Cladribine—hematologic cancer	0.00422	0.0205	CrCrCtD
Fludarabine—Nelarabine—Cytarabine—hematologic cancer	0.00383	0.0186	CrCrCtD
Fludarabine—Adenosine monophosphate—Cytarabine—hematologic cancer	0.00383	0.0186	CrCrCtD
Fludarabine—Nelarabine—Cladribine—hematologic cancer	0.00373	0.0181	CrCrCtD
Fludarabine—Adenosine monophosphate—Cladribine—hematologic cancer	0.00373	0.0181	CrCrCtD
Fludarabine—Cytarabine—Gemcitabine—hematologic cancer	0.00362	0.0176	CrCrCtD
Fludarabine—Azacitidine—Cytarabine—hematologic cancer	0.00344	0.0167	CrCrCtD
Fludarabine—Azacitidine—Gemcitabine—hematologic cancer	0.00344	0.0167	CrCrCtD
Fludarabine—Adenosine—Cytarabine—hematologic cancer	0.00344	0.0167	CrCrCtD
Fludarabine—Vidarabine—Cytarabine—hematologic cancer	0.00344	0.0167	CrCrCtD
Fludarabine—Vidarabine—Cladribine—hematologic cancer	0.00335	0.0163	CrCrCtD
Fludarabine—Adenosine—Cladribine—hematologic cancer	0.00335	0.0163	CrCrCtD
Fludarabine—Azacitidine—Cladribine—hematologic cancer	0.00335	0.0163	CrCrCtD
Fludarabine—POLA1—hematopoietic system—hematologic cancer	0.000777	0.0667	CbGeAlD
Fludarabine—SLC28A3—bone marrow—hematologic cancer	0.000709	0.0608	CbGeAlD
Fludarabine—SLC28A3—lung—hematologic cancer	0.000643	0.0551	CbGeAlD
Fludarabine—RRM1—hematopoietic system—hematologic cancer	0.000617	0.0529	CbGeAlD
Fludarabine—POLA1—blood—hematologic cancer	0.000515	0.0442	CbGeAlD
Fludarabine—SLC29A1—hematopoietic system—hematologic cancer	0.000502	0.043	CbGeAlD
Fludarabine—POLA1—bone marrow—hematologic cancer	0.000498	0.0427	CbGeAlD
Fludarabine—DCK—hematopoietic system—hematologic cancer	0.000479	0.0411	CbGeAlD
Fludarabine—RRM1—gonad—hematologic cancer	0.000469	0.0402	CbGeAlD
Fludarabine—POLA1—lung—hematologic cancer	0.000451	0.0387	CbGeAlD
Fludarabine—POLA1—testis—hematologic cancer	0.000426	0.0365	CbGeAlD
Fludarabine—RRM1—blood—hematologic cancer	0.000409	0.035	CbGeAlD
Fludarabine—RRM1—bone marrow—hematologic cancer	0.000396	0.0339	CbGeAlD
Fludarabine—SLC29A1—gonad—hematologic cancer	0.000381	0.0327	CbGeAlD
Fludarabine—DCK—gonad—hematologic cancer	0.000364	0.0312	CbGeAlD
Fludarabine—RRM1—lung—hematologic cancer	0.000358	0.0307	CbGeAlD
Fludarabine—RRM1—testis—hematologic cancer	0.000338	0.029	CbGeAlD
Fludarabine—SLC29A1—blood—hematologic cancer	0.000332	0.0285	CbGeAlD
Fludarabine—SLC29A1—bone marrow—hematologic cancer	0.000322	0.0276	CbGeAlD
Fludarabine—DCK—blood—hematologic cancer	0.000318	0.0272	CbGeAlD
Fludarabine—POLA1—lymph node—hematologic cancer	0.000309	0.0265	CbGeAlD
Fludarabine—DCK—bone marrow—hematologic cancer	0.000307	0.0263	CbGeAlD
Fludarabine—SLC29A1—lung—hematologic cancer	0.000291	0.025	CbGeAlD
Fludarabine—DCK—lung—hematologic cancer	0.000278	0.0239	CbGeAlD
Fludarabine—SLC29A1—testis—hematologic cancer	0.000275	0.0236	CbGeAlD
Fludarabine—DCK—testis—hematologic cancer	0.000263	0.0225	CbGeAlD
Fludarabine—RRM1—lymph node—hematologic cancer	0.000245	0.021	CbGeAlD
Fludarabine—SLC29A1—lymph node—hematologic cancer	0.000199	0.0171	CbGeAlD
Fludarabine—Azacitidine—DNMT3A—hematologic cancer	0.000192	0.127	CrCbGaD
Fludarabine—DCK—lymph node—hematologic cancer	0.00019	0.0163	CbGeAlD
Fludarabine—Azacitidine—CDA—hematologic cancer	0.000171	0.113	CrCbGaD
Fludarabine—Nelarabine—DCK—hematologic cancer	0.000141	0.0934	CrCbGaD
Fludarabine—Clofarabine—DCK—hematologic cancer	0.000138	0.0909	CrCbGaD
Fludarabine—Adenosine triphosphate—ASNS—hematologic cancer	0.000101	0.0665	CrCbGaD
Fludarabine—Cytarabine—CDA—hematologic cancer	9.75e-05	0.0644	CrCbGaD
Fludarabine—DCK—Topotecan—Irinotecan—hematologic cancer	9.01e-05	0.0922	CbGdCrCtD
Fludarabine—Adenosine monophosphate—CREB1—hematologic cancer	8.8e-05	0.0581	CrCbGaD
Fludarabine—Cytarabine—DCK—hematologic cancer	8.58e-05	0.0567	CrCbGaD
Fludarabine—POLA1—Vinblastine—Vinorelbine—hematologic cancer	8.48e-05	0.0867	CbGdCrCtD
Fludarabine—Cladribine—DCK—hematologic cancer	7.9e-05	0.0522	CrCbGaD
Fludarabine—Adenosine triphosphate—ABL2—hematologic cancer	7.63e-05	0.0504	CrCbGaD
Fludarabine—RRM1—Azacitidine—Pentostatin—hematologic cancer	7.44e-05	0.0761	CbGdCrCtD
Fludarabine—POLA1—Vinblastine—Vincristine—hematologic cancer	6.78e-05	0.0693	CbGdCrCtD
Fludarabine—RRM1—Azacitidine—Clofarabine—hematologic cancer	6.63e-05	0.0678	CbGdCrCtD
Fludarabine—RRM1—Azacitidine—Nelarabine—hematologic cancer	6.23e-05	0.0638	CbGdCrCtD
Fludarabine—DCK—Doxorubicin—Daunorubicin—hematologic cancer	6.08e-05	0.0623	CbGdCrCtD
Fludarabine—DCK—Epirubicin—Daunorubicin—hematologic cancer	6.08e-05	0.0623	CbGdCrCtD
Fludarabine—Flavin adenine dinucleotide—NQO1—hematologic cancer	5.29e-05	0.0349	CrCbGaD
Fludarabine—DCK—Menadione—Thalidomide—hematologic cancer	5.17e-05	0.0529	CbGdCrCtD
Fludarabine—Adenosine triphosphate—ALK—hematologic cancer	4.62e-05	0.0305	CrCbGaD
Fludarabine—DCK—Epirubicin—Idarubicin—hematologic cancer	4.61e-05	0.0472	CbGdCrCtD
Fludarabine—DCK—Doxorubicin—Idarubicin—hematologic cancer	4.61e-05	0.0472	CbGdCrCtD
Fludarabine—RRM1—Azacitidine—Cytarabine—hematologic cancer	4.59e-05	0.047	CbGdCrCtD
Fludarabine—RRM1—Azacitidine—Gemcitabine—hematologic cancer	4.59e-05	0.047	CbGdCrCtD
Fludarabine—RRM1—Azacitidine—Cladribine—hematologic cancer	4.48e-05	0.0458	CbGdCrCtD
Fludarabine—Adenosine triphosphate—AKT1—hematologic cancer	3.61e-05	0.0238	CrCbGaD
Fludarabine—Adenosine monophosphate—SRC—hematologic cancer	3.56e-05	0.0235	CrCbGaD
Fludarabine—Adenosine triphosphate—ABL1—hematologic cancer	3.41e-05	0.0225	CrCbGaD
Fludarabine—Adenosine monophosphate—PDE4B—hematologic cancer	3.18e-05	0.021	CrCbGaD
Fludarabine—Clofarabine—ABCG2—hematologic cancer	3.1e-05	0.0205	CrCbGaD
Fludarabine—Cytarabine—SLC22A1—hematologic cancer	2.77e-05	0.0183	CrCbGaD
Fludarabine—Cladribine—SLC22A1—hematologic cancer	2.55e-05	0.0168	CrCbGaD
Fludarabine—DCK—Doxorubicin—Epirubicin—hematologic cancer	2.12e-05	0.0217	CbGdCrCtD
Fludarabine—DCK—Epirubicin—Doxorubicin—hematologic cancer	1.96e-05	0.02	CbGdCrCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ABCB1—hematologic cancer	1.87e-05	0.000925	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—STAG2—hematologic cancer	1.86e-05	0.000922	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—EP300—hematologic cancer	1.84e-05	0.000908	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1B—hematologic cancer	1.82e-05	0.000899	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ASNS—hematologic cancer	1.8e-05	0.000889	CbGpPWpGaD
Fludarabine—DCK—Metabolism—B3GAT1—hematologic cancer	1.8e-05	0.000889	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—FGF1—hematologic cancer	1.79e-05	0.000888	CbGpPWpGaD
Fludarabine—Cladribine—ABCG2—hematologic cancer	1.78e-05	0.0118	CrCbGaD
Fludarabine—POLA1—S Phase—RB1—hematologic cancer	1.77e-05	0.000875	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—BAX—hematologic cancer	1.77e-05	0.000875	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—SMC1A—hematologic cancer	1.75e-05	0.000863	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PDGFRA—hematologic cancer	1.74e-05	0.00086	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—hematologic cancer	1.73e-05	0.000858	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—MTAP—hematologic cancer	1.72e-05	0.000852	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.72e-05	0.000851	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	1.72e-05	0.000851	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—H3F3A—hematologic cancer	1.71e-05	0.000846	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—H3F3B—hematologic cancer	1.71e-05	0.000843	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—FOXM1—hematologic cancer	1.71e-05	0.000843	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HDC—hematologic cancer	1.7e-05	0.000843	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	1.69e-05	0.000834	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	1.69e-05	0.000834	CbGpPWpGaD
Fludarabine—POLA1—Synthesis of DNA—CDKN1B—hematologic cancer	1.68e-05	0.000831	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1A—hematologic cancer	1.68e-05	0.00083	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—STAG2—hematologic cancer	1.67e-05	0.000825	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—RB1—hematologic cancer	1.64e-05	0.000813	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	1.64e-05	0.000812	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	1.64e-05	0.00081	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	1.63e-05	0.000805	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.62e-05	0.0008	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CCND3—hematologic cancer	1.61e-05	0.000798	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—MYC—hematologic cancer	1.6e-05	0.000792	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	1.59e-05	0.000785	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	1.58e-05	0.000783	CbGpPWpGaD
Fludarabine—POLA1—DNA Replication—CDKN1B—hematologic cancer	1.58e-05	0.000779	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—hematologic cancer	1.56e-05	0.000772	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CDA—hematologic cancer	1.56e-05	0.000771	CbGpPWpGaD
Fludarabine—POLA1—Synthesis of DNA—CDKN1A—hematologic cancer	1.55e-05	0.000767	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	1.55e-05	0.000766	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—NUP98—hematologic cancer	1.54e-05	0.000759	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—FHL2—hematologic cancer	1.53e-05	0.000759	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—FOXM1—hematologic cancer	1.53e-05	0.000754	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—H3F3B—hematologic cancer	1.53e-05	0.000754	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—CDKN1B—hematologic cancer	1.52e-05	0.000751	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	1.51e-05	0.000749	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	1.51e-05	0.000747	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—AGRN—hematologic cancer	1.51e-05	0.000744	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PC—hematologic cancer	1.5e-05	0.000742	CbGpPWpGaD
Fludarabine—SLC29A1—SLC-mediated transmembrane transport—ALB—hematologic cancer	1.48e-05	0.000734	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—NUP214—hematologic cancer	1.48e-05	0.000732	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	1.47e-05	0.000727	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—NPM1—hematologic cancer	1.47e-05	0.000726	CbGpPWpGaD
Fludarabine—POLA1—DNA Replication—CDKN1A—hematologic cancer	1.45e-05	0.000719	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	1.45e-05	0.000719	CbGpPWpGaD
Fludarabine—DCK—Metabolism—SLC35B2—hematologic cancer	1.45e-05	0.000717	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GBA—hematologic cancer	1.45e-05	0.000717	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.44e-05	0.000714	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—hematologic cancer	1.44e-05	0.000714	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CCND3—hematologic cancer	1.44e-05	0.000713	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	1.44e-05	0.000711	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	1.43e-05	0.000708	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	1.43e-05	0.000708	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—IDH2—hematologic cancer	1.43e-05	0.000706	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HMMR—hematologic cancer	1.43e-05	0.000706	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	1.43e-05	0.000705	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—CDKN1A—hematologic cancer	1.4e-05	0.000693	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	1.39e-05	0.000688	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	1.39e-05	0.000688	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—hematologic cancer	1.39e-05	0.000688	CbGpPWpGaD
Fludarabine—POLA1—S Phase—CDKN1B—hematologic cancer	1.38e-05	0.000682	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—NUP98—hematologic cancer	1.37e-05	0.000679	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	1.35e-05	0.000669	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ARNTL—hematologic cancer	1.34e-05	0.000663	CbGpPWpGaD
Fludarabine—DCK—Metabolism—MTAP—hematologic cancer	1.33e-05	0.000655	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—NUP214—hematologic cancer	1.32e-05	0.000655	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	1.32e-05	0.000651	CbGpPWpGaD
Fludarabine—POLA1—S Phase—CCND1—hematologic cancer	1.31e-05	0.00065	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	1.31e-05	0.00065	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—SMC1A—hematologic cancer	1.31e-05	0.000646	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ACP5—hematologic cancer	1.31e-05	0.000645	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CA9—hematologic cancer	1.31e-05	0.000645	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—TOP2A—hematologic cancer	1.29e-05	0.000639	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NCOR2—hematologic cancer	1.29e-05	0.000637	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	1.28e-05	0.000634	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—H3F3A—hematologic cancer	1.28e-05	0.000633	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—hematologic cancer	1.28e-05	0.000633	CbGpPWpGaD
Fludarabine—POLA1—S Phase—CDKN1A—hematologic cancer	1.27e-05	0.000629	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	1.26e-05	0.000621	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	1.25e-05	0.000618	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—IDH1—hematologic cancer	1.23e-05	0.000607	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.23e-05	0.000607	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CCND1—hematologic cancer	1.22e-05	0.000604	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MLH1—hematologic cancer	1.22e-05	0.000603	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.22e-05	0.000602	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ABCC3—hematologic cancer	1.21e-05	0.0006	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—TXN—hematologic cancer	1.21e-05	0.0006	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTO1—hematologic cancer	1.21e-05	0.0006	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.21e-05	0.000596	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDK6—hematologic cancer	1.2e-05	0.000594	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	1.19e-05	0.00059	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SPHK1—hematologic cancer	1.19e-05	0.000587	CbGpPWpGaD
Fludarabine—DCK—Metabolism—FHL2—hematologic cancer	1.18e-05	0.000584	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—hematologic cancer	1.18e-05	0.000584	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—SMC1A—hematologic cancer	1.17e-05	0.000577	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—MYC—hematologic cancer	1.16e-05	0.000574	CbGpPWpGaD
Fludarabine—DCK—Metabolism—AGRN—hematologic cancer	1.16e-05	0.000573	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—TOP2A—hematologic cancer	1.16e-05	0.000572	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—H3F3A—hematologic cancer	1.14e-05	0.000566	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—hematologic cancer	1.14e-05	0.000565	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—UGT1A1—hematologic cancer	1.14e-05	0.000564	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	1.13e-05	0.000561	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.12e-05	0.000553	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CRABP1—hematologic cancer	1.11e-05	0.000549	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SLC22A1—hematologic cancer	1.11e-05	0.000549	CbGpPWpGaD
Fludarabine—DCK—Metabolism—IDH2—hematologic cancer	1.1e-05	0.000543	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HMMR—hematologic cancer	1.1e-05	0.000543	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ALOX5—hematologic cancer	1.08e-05	0.000535	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.08e-05	0.000535	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.08e-05	0.000534	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—HSP90AA1—hematologic cancer	1.08e-05	0.000533	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	1.08e-05	0.000533	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDK6—hematologic cancer	1.07e-05	0.000531	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—BIRC5—hematologic cancer	1.07e-05	0.000529	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	1.06e-05	0.000525	CbGpPWpGaD
Fludarabine—POLA1—S Phase—MYC—hematologic cancer	1.05e-05	0.000522	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NUP98—hematologic cancer	1.05e-05	0.000518	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CCND2—hematologic cancer	1.03e-05	0.000511	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ARNTL—hematologic cancer	1.03e-05	0.000511	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ADCY7—hematologic cancer	1.02e-05	0.000503	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NCOA3—hematologic cancer	1.02e-05	0.000503	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—ALB—hematologic cancer	1.01e-05	0.0005	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NUP214—hematologic cancer	1.01e-05	0.000499	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CA9—hematologic cancer	1e-05	0.000497	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ACP5—hematologic cancer	1e-05	0.000497	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NCOR2—hematologic cancer	9.91e-06	0.00049	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—MTR—hematologic cancer	9.89e-06	0.000489	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ABCG2—hematologic cancer	9.89e-06	0.000489	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—CDK2—hematologic cancer	9.8e-06	0.000485	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—MYC—hematologic cancer	9.79e-06	0.000484	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ENO2—hematologic cancer	9.7e-06	0.00048	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	9.69e-06	0.000479	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—HSP90AA1—hematologic cancer	9.64e-06	0.000477	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	9.5e-06	0.00047	CbGpPWpGaD
Fludarabine—DCK—Metabolism—IDH1—hematologic cancer	9.44e-06	0.000467	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTT1—hematologic cancer	9.41e-06	0.000465	CbGpPWpGaD
Fludarabine—DCK—Desoximetasone—Dexamethasone—hematologic cancer	9.35e-06	0.00957	CbGdCrCtD
Fludarabine—DCK—Desoximetasone—Betamethasone—hematologic cancer	9.35e-06	0.00957	CbGdCrCtD
Fludarabine—DCK—Metabolism—GSTO1—hematologic cancer	9.34e-06	0.000462	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ABCC3—hematologic cancer	9.34e-06	0.000462	CbGpPWpGaD
Fludarabine—DCK—Metabolism—TXN—hematologic cancer	9.34e-06	0.000462	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN2B—hematologic cancer	9.26e-06	0.000458	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	9.25e-06	0.000457	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CCND2—hematologic cancer	9.24e-06	0.000457	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	9.23e-06	0.000456	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SDC1—hematologic cancer	9.2e-06	0.000455	CbGpPWpGaD
Fludarabine—DCK—Metabolism—SPHK1—hematologic cancer	9.14e-06	0.000452	CbGpPWpGaD
Fludarabine—DCK—Desoximetasone—Triamcinolone—hematologic cancer	9.14e-06	0.00935	CbGdCrCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	9.13e-06	0.000452	CbGpPWpGaD
Fludarabine—DCK—Diflorasone—Betamethasone—hematologic cancer	9.07e-06	0.00929	CbGdCrCtD
Fludarabine—DCK—Diflorasone—Dexamethasone—hematologic cancer	9.07e-06	0.00929	CbGdCrCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	8.94e-06	0.000442	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	8.92e-06	0.000441	CbGpPWpGaD
Fludarabine—DCK—Diflorasone—Triamcinolone—hematologic cancer	8.87e-06	0.00907	CbGdCrCtD
Fludarabine—DCK—Metabolism—UGT1A1—hematologic cancer	8.78e-06	0.000434	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	8.73e-06	0.000432	CbGpPWpGaD
Fludarabine—DCK—Desoximetasone—Prednisone—hematologic cancer	8.67e-06	0.00887	CbGdCrCtD
Fludarabine—DCK—Metabolism—SLC22A1—hematologic cancer	8.54e-06	0.000422	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CRABP1—hematologic cancer	8.54e-06	0.000422	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	8.51e-06	0.000421	CbGpPWpGaD
Fludarabine—DCK—Desoximetasone—Prednisolone—hematologic cancer	8.46e-06	0.00866	CbGdCrCtD
Fludarabine—DCK—Diflorasone—Prednisone—hematologic cancer	8.41e-06	0.00861	CbGdCrCtD
Fludarabine—DCK—Metabolism—ALOX5—hematologic cancer	8.32e-06	0.000412	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDKN2B—hematologic cancer	8.28e-06	0.00041	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	8.28e-06	0.000409	CbGpPWpGaD
Fludarabine—DCK—Diflorasone—Prednisolone—hematologic cancer	8.21e-06	0.00841	CbGdCrCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	8.06e-06	0.000399	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NUP98—hematologic cancer	8.06e-06	0.000399	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—RB1—hematologic cancer	8.06e-06	0.000398	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	8.06e-06	0.000398	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—BIRC5—hematologic cancer	7.99e-06	0.000395	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ADCY7—hematologic cancer	7.82e-06	0.000387	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NCOA3—hematologic cancer	7.82e-06	0.000387	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NQO1—hematologic cancer	7.82e-06	0.000387	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CD44—hematologic cancer	7.82e-06	0.000387	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NUP214—hematologic cancer	7.77e-06	0.000384	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	7.62e-06	0.000377	CbGpPWpGaD
Fludarabine—DCK—Metabolism—MTR—hematologic cancer	7.61e-06	0.000376	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ABCG2—hematologic cancer	7.61e-06	0.000376	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ALB—hematologic cancer	7.54e-06	0.000373	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ENO2—hematologic cancer	7.46e-06	0.000369	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	7.42e-06	0.000367	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CYCS—hematologic cancer	7.4e-06	0.000366	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	7.4e-06	0.000366	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HSP90AA1—hematologic cancer	7.35e-06	0.000364	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDK2—hematologic cancer	7.33e-06	0.000363	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTT1—hematologic cancer	7.24e-06	0.000358	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—BIRC5—hematologic cancer	7.15e-06	0.000353	CbGpPWpGaD
Fludarabine—DCK—Metabolism—SDC1—hematologic cancer	7.08e-06	0.00035	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDK4—hematologic cancer	6.93e-06	0.000343	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—TERT—hematologic cancer	6.92e-06	0.000342	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	6.91e-06	0.000342	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	6.85e-06	0.000339	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDK2—hematologic cancer	6.56e-06	0.000324	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTP1—hematologic cancer	6.52e-06	0.000322	CbGpPWpGaD
Fludarabine—Adenosine triphosphate—ABCB1—hematologic cancer	6.3e-06	0.00416	CrCbGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	6.3e-06	0.000311	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—ATM—hematologic cancer	6.22e-06	0.000308	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDK4—hematologic cancer	6.2e-06	0.000306	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ABCB1—hematologic cancer	6.17e-06	0.000305	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	6.09e-06	0.000301	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—RB1—hematologic cancer	6.03e-06	0.000298	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NQO1—hematologic cancer	6.02e-06	0.000298	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CD44—hematologic cancer	6.02e-06	0.000298	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NCOR1—hematologic cancer	5.99e-06	0.000296	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTM1—hematologic cancer	5.99e-06	0.000296	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYCS—hematologic cancer	5.69e-06	0.000282	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HSP90AA1—hematologic cancer	5.66e-06	0.00028	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—RB1—hematologic cancer	5.39e-06	0.000266	CbGpPWpGaD
Fludarabine—Anorexia—Betamethasone—hematologic cancer	5.32e-06	8.48e-05	CcSEcCtD
Fludarabine—Asthenia—Cisplatin—hematologic cancer	5.31e-06	8.47e-05	CcSEcCtD
Fludarabine—Pharyngitis—Epirubicin—hematologic cancer	5.31e-06	8.46e-05	CcSEcCtD
Fludarabine—Fatigue—Triamcinolone—hematologic cancer	5.31e-06	8.45e-05	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—hematologic cancer	5.3e-06	0.000262	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—MTHFR—hematologic cancer	5.3e-06	0.000262	CbGpPWpGaD
Fludarabine—Rash—Vincristine—hematologic cancer	5.28e-06	8.41e-05	CcSEcCtD
Fludarabine—Dermatitis—Vincristine—hematologic cancer	5.28e-06	8.41e-05	CcSEcCtD
Fludarabine—Pain—Triamcinolone—hematologic cancer	5.26e-06	8.38e-05	CcSEcCtD
Fludarabine—Haematuria—Doxorubicin—hematologic cancer	5.26e-06	8.38e-05	CcSEcCtD
Fludarabine—Headache—Vincristine—hematologic cancer	5.25e-06	8.36e-05	CcSEcCtD
Fludarabine—Nausea—Carmustine—hematologic cancer	5.21e-06	8.3e-05	CcSEcCtD
Fludarabine—Epistaxis—Doxorubicin—hematologic cancer	5.2e-06	8.29e-05	CcSEcCtD
Fludarabine—Vomiting—Mitoxantrone—hematologic cancer	5.19e-06	8.26e-05	CcSEcCtD
Fludarabine—Vomiting—Irinotecan—hematologic cancer	5.19e-06	8.26e-05	CcSEcCtD
Fludarabine—Sinusitis—Doxorubicin—hematologic cancer	5.18e-06	8.25e-05	CcSEcCtD
Fludarabine—Nausea—Alitretinoin—hematologic cancer	5.16e-06	8.23e-05	CcSEcCtD
Fludarabine—Convulsion—Prednisone—hematologic cancer	5.16e-06	8.22e-05	CcSEcCtD
Fludarabine—Visual impairment—Epirubicin—hematologic cancer	5.16e-06	8.22e-05	CcSEcCtD
Fludarabine—Rash—Irinotecan—hematologic cancer	5.14e-06	8.19e-05	CcSEcCtD
Fludarabine—Rash—Mitoxantrone—hematologic cancer	5.14e-06	8.19e-05	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	5.14e-06	0.000254	CbGpPWpGaD
Fludarabine—Dermatitis—Mitoxantrone—hematologic cancer	5.14e-06	8.19e-05	CcSEcCtD
Fludarabine—Dermatitis—Irinotecan—hematologic cancer	5.14e-06	8.19e-05	CcSEcCtD
Fludarabine—Chills—Methotrexate—hematologic cancer	5.13e-06	8.18e-05	CcSEcCtD
Fludarabine—Headache—Mitoxantrone—hematologic cancer	5.11e-06	8.14e-05	CcSEcCtD
Fludarabine—Headache—Irinotecan—hematologic cancer	5.11e-06	8.14e-05	CcSEcCtD
Fludarabine—Nausea—Ifosfamide—hematologic cancer	5.1e-06	8.13e-05	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	5.09e-06	8.11e-05	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	5.09e-06	8.11e-05	CcSEcCtD
Fludarabine—Arthralgia—Prednisone—hematologic cancer	5.07e-06	8.08e-05	CcSEcCtD
Fludarabine—Myalgia—Prednisone—hematologic cancer	5.07e-06	8.08e-05	CcSEcCtD
Fludarabine—Feeling abnormal—Triamcinolone—hematologic cancer	5.07e-06	8.08e-05	CcSEcCtD
Fludarabine—Diarrhoea—Cisplatin—hematologic cancer	5.07e-06	8.07e-05	CcSEcCtD
Fludarabine—Erythema multiforme—Epirubicin—hematologic cancer	5.06e-06	8.06e-05	CcSEcCtD
Fludarabine—Alopecia—Methotrexate—hematologic cancer	5.06e-06	8.05e-05	CcSEcCtD
Fludarabine—Vomiting—Gemcitabine—hematologic cancer	5.05e-06	8.05e-05	CcSEcCtD
Fludarabine—DCK—Metabolism—GSTP1—hematologic cancer	5.02e-06	0.000248	CbGpPWpGaD
Fludarabine—Paraesthesia—Betamethasone—hematologic cancer	5.01e-06	7.99e-05	CcSEcCtD
Fludarabine—Paraesthesia—Dexamethasone—hematologic cancer	5.01e-06	7.99e-05	CcSEcCtD
Fludarabine—Discomfort—Prednisone—hematologic cancer	5.01e-06	7.99e-05	CcSEcCtD
Fludarabine—Rash—Gemcitabine—hematologic cancer	5.01e-06	7.98e-05	CcSEcCtD
Fludarabine—Dermatitis—Gemcitabine—hematologic cancer	5.01e-06	7.97e-05	CcSEcCtD
Fludarabine—Hypersensitivity—Etoposide—hematologic cancer	5e-06	7.96e-05	CcSEcCtD
Fludarabine—Malnutrition—Methotrexate—hematologic cancer	4.98e-06	7.93e-05	CcSEcCtD
Fludarabine—Haemoglobin—Doxorubicin—hematologic cancer	4.98e-06	7.93e-05	CcSEcCtD
Fludarabine—Headache—Gemcitabine—hematologic cancer	4.98e-06	7.93e-05	CcSEcCtD
Fludarabine—Nausea—Vincristine—hematologic cancer	4.98e-06	7.93e-05	CcSEcCtD
Fludarabine—Haemorrhage—Doxorubicin—hematologic cancer	4.95e-06	7.89e-05	CcSEcCtD
Fludarabine—POLA1—Mitotic M-M/G1 phases—MAPK3—hematologic cancer	4.94e-06	0.000244	CbGpPWpGaD
Fludarabine—Hypersensitivity—Prednisolone—hematologic cancer	4.93e-06	7.86e-05	CcSEcCtD
Fludarabine—Hypoaesthesia—Doxorubicin—hematologic cancer	4.93e-06	7.85e-05	CcSEcCtD
Fludarabine—Pharyngitis—Doxorubicin—hematologic cancer	4.92e-06	7.83e-05	CcSEcCtD
Fludarabine—Dyspepsia—Dexamethasone—hematologic cancer	4.92e-06	7.83e-05	CcSEcCtD
Fludarabine—Dyspepsia—Betamethasone—hematologic cancer	4.92e-06	7.83e-05	CcSEcCtD
Fludarabine—Asthenia—Etoposide—hematologic cancer	4.87e-06	7.76e-05	CcSEcCtD
Fludarabine—Body temperature increased—Triamcinolone—hematologic cancer	4.87e-06	7.75e-05	CcSEcCtD
Fludarabine—Oedema—Prednisone—hematologic cancer	4.86e-06	7.75e-05	CcSEcCtD
Fludarabine—Anaphylactic shock—Prednisone—hematologic cancer	4.86e-06	7.75e-05	CcSEcCtD
Fludarabine—Decreased appetite—Betamethasone—hematologic cancer	4.85e-06	7.73e-05	CcSEcCtD
Fludarabine—Decreased appetite—Dexamethasone—hematologic cancer	4.85e-06	7.73e-05	CcSEcCtD
Fludarabine—Nausea—Irinotecan—hematologic cancer	4.85e-06	7.72e-05	CcSEcCtD
Fludarabine—Nausea—Mitoxantrone—hematologic cancer	4.85e-06	7.72e-05	CcSEcCtD
Fludarabine—Infection—Prednisone—hematologic cancer	4.83e-06	7.7e-05	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Betamethasone—hematologic cancer	4.82e-06	7.68e-05	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	4.82e-06	7.68e-05	CcSEcCtD
Fludarabine—Fatigue—Betamethasone—hematologic cancer	4.81e-06	7.67e-05	CcSEcCtD
Fludarabine—Fatigue—Dexamethasone—hematologic cancer	4.81e-06	7.67e-05	CcSEcCtD
Fludarabine—Chills—Epirubicin—hematologic cancer	4.8e-06	7.65e-05	CcSEcCtD
Fludarabine—Pruritus—Etoposide—hematologic cancer	4.8e-06	7.65e-05	CcSEcCtD
Fludarabine—Arrhythmia—Epirubicin—hematologic cancer	4.78e-06	7.62e-05	CcSEcCtD
Fludarabine—Pain—Dexamethasone—hematologic cancer	4.78e-06	7.61e-05	CcSEcCtD
Fludarabine—Pain—Betamethasone—hematologic cancer	4.78e-06	7.61e-05	CcSEcCtD
Fludarabine—Visual impairment—Doxorubicin—hematologic cancer	4.77e-06	7.61e-05	CcSEcCtD
Fludarabine—Nervous system disorder—Prednisone—hematologic cancer	4.77e-06	7.6e-05	CcSEcCtD
Fludarabine—DCK—Metabolism—ABCB1—hematologic cancer	4.75e-06	0.000235	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDKN2A—hematologic cancer	4.74e-06	0.000234	CbGpPWpGaD
Fludarabine—Alopecia—Epirubicin—hematologic cancer	4.73e-06	7.54e-05	CcSEcCtD
Fludarabine—Nausea—Gemcitabine—hematologic cancer	4.72e-06	7.52e-05	CcSEcCtD
Fludarabine—Vomiting—Cisplatin—hematologic cancer	4.71e-06	7.5e-05	CcSEcCtD
Fludarabine—Hyperhidrosis—Prednisone—hematologic cancer	4.7e-06	7.49e-05	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	4.69e-06	0.000232	CbGpPWpGaD
Fludarabine—Erythema multiforme—Doxorubicin—hematologic cancer	4.68e-06	7.46e-05	CcSEcCtD
Fludarabine—Rash—Cisplatin—hematologic cancer	4.67e-06	7.44e-05	CcSEcCtD
Fludarabine—Dermatitis—Cisplatin—hematologic cancer	4.67e-06	7.43e-05	CcSEcCtD
Fludarabine—Malnutrition—Epirubicin—hematologic cancer	4.66e-06	7.42e-05	CcSEcCtD
Fludarabine—Diarrhoea—Etoposide—hematologic cancer	4.64e-06	7.4e-05	CcSEcCtD
Fludarabine—Anorexia—Prednisone—hematologic cancer	4.64e-06	7.39e-05	CcSEcCtD
Fludarabine—Ill-defined disorder—Methotrexate—hematologic cancer	4.62e-06	7.36e-05	CcSEcCtD
Fludarabine—DCK—Metabolism—GSTM1—hematologic cancer	4.61e-06	0.000228	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NCOR1—hematologic cancer	4.61e-06	0.000228	CbGpPWpGaD
Fludarabine—Anaemia—Methotrexate—hematologic cancer	4.6e-06	7.33e-05	CcSEcCtD
Fludarabine—Feeling abnormal—Dexamethasone—hematologic cancer	4.6e-06	7.33e-05	CcSEcCtD
Fludarabine—Feeling abnormal—Betamethasone—hematologic cancer	4.6e-06	7.33e-05	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—MDM2—hematologic cancer	4.59e-06	0.000227	CbGpPWpGaD
Fludarabine—Hypersensitivity—Triamcinolone—hematologic cancer	4.53e-06	7.22e-05	CcSEcCtD
Fludarabine—Malaise—Methotrexate—hematologic cancer	4.49e-06	7.15e-05	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—CCND1—hematologic cancer	4.48e-06	0.000221	CbGpPWpGaD
Fludarabine—Leukopenia—Methotrexate—hematologic cancer	4.46e-06	7.1e-05	CcSEcCtD
Fludarabine—RRM1—Metabolism—PIK3CG—hematologic cancer	4.45e-06	0.00022	CbGpPWpGaD
Fludarabine—Chills—Doxorubicin—hematologic cancer	4.44e-06	7.08e-05	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.43e-06	7.06e-05	CcSEcCtD
Fludarabine—Arrhythmia—Doxorubicin—hematologic cancer	4.43e-06	7.05e-05	CcSEcCtD
Fludarabine—Asthenia—Triamcinolone—hematologic cancer	4.42e-06	7.03e-05	CcSEcCtD
Fludarabine—Body temperature increased—Dexamethasone—hematologic cancer	4.41e-06	7.03e-05	CcSEcCtD
Fludarabine—Body temperature increased—Betamethasone—hematologic cancer	4.41e-06	7.03e-05	CcSEcCtD
Fludarabine—Nausea—Cisplatin—hematologic cancer	4.4e-06	7.01e-05	CcSEcCtD
Fludarabine—Alopecia—Doxorubicin—hematologic cancer	4.38e-06	6.97e-05	CcSEcCtD
Fludarabine—Paraesthesia—Prednisone—hematologic cancer	4.37e-06	6.96e-05	CcSEcCtD
Fludarabine—Pruritus—Triamcinolone—hematologic cancer	4.35e-06	6.94e-05	CcSEcCtD
Fludarabine—Cough—Methotrexate—hematologic cancer	4.35e-06	6.92e-05	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	4.33e-06	0.000214	CbGpPWpGaD
Fludarabine—Ill-defined disorder—Epirubicin—hematologic cancer	4.32e-06	6.89e-05	CcSEcCtD
Fludarabine—Convulsion—Methotrexate—hematologic cancer	4.31e-06	6.87e-05	CcSEcCtD
Fludarabine—Vomiting—Etoposide—hematologic cancer	4.31e-06	6.87e-05	CcSEcCtD
Fludarabine—Malnutrition—Doxorubicin—hematologic cancer	4.31e-06	6.87e-05	CcSEcCtD
Fludarabine—Anaemia—Epirubicin—hematologic cancer	4.31e-06	6.86e-05	CcSEcCtD
Fludarabine—Agitation—Epirubicin—hematologic cancer	4.28e-06	6.82e-05	CcSEcCtD
Fludarabine—Dyspepsia—Prednisone—hematologic cancer	4.28e-06	6.82e-05	CcSEcCtD
Fludarabine—Rash—Etoposide—hematologic cancer	4.28e-06	6.82e-05	CcSEcCtD
Fludarabine—Dermatitis—Etoposide—hematologic cancer	4.27e-06	6.81e-05	CcSEcCtD
Fludarabine—Headache—Etoposide—hematologic cancer	4.25e-06	6.77e-05	CcSEcCtD
Fludarabine—Myalgia—Methotrexate—hematologic cancer	4.24e-06	6.75e-05	CcSEcCtD
Fludarabine—Arthralgia—Methotrexate—hematologic cancer	4.24e-06	6.75e-05	CcSEcCtD
Fludarabine—Decreased appetite—Prednisone—hematologic cancer	4.23e-06	6.73e-05	CcSEcCtD
Fludarabine—Rash—Prednisolone—hematologic cancer	4.22e-06	6.72e-05	CcSEcCtD
Fludarabine—Dermatitis—Prednisolone—hematologic cancer	4.22e-06	6.72e-05	CcSEcCtD
Fludarabine—Malaise—Epirubicin—hematologic cancer	4.2e-06	6.7e-05	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—CDKN1B—hematologic cancer	4.19e-06	0.000207	CbGpPWpGaD
Fludarabine—Fatigue—Prednisone—hematologic cancer	4.19e-06	6.68e-05	CcSEcCtD
Fludarabine—Headache—Prednisolone—hematologic cancer	4.19e-06	6.68e-05	CcSEcCtD
Fludarabine—Discomfort—Methotrexate—hematologic cancer	4.19e-06	6.67e-05	CcSEcCtD
Fludarabine—Leukopenia—Epirubicin—hematologic cancer	4.17e-06	6.65e-05	CcSEcCtD
Fludarabine—Constipation—Prednisone—hematologic cancer	4.16e-06	6.63e-05	CcSEcCtD
Fludarabine—RRM1—Metabolism—CREBBP—hematologic cancer	4.13e-06	0.000204	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—EP300—hematologic cancer	4.12e-06	0.000204	CbGpPWpGaD
Fludarabine—Confusional state—Methotrexate—hematologic cancer	4.1e-06	6.53e-05	CcSEcCtD
Fludarabine—DCK—Metabolism—MTHFR—hematologic cancer	4.08e-06	0.000202	CbGpPWpGaD
Fludarabine—Cough—Epirubicin—hematologic cancer	4.07e-06	6.48e-05	CcSEcCtD
Fludarabine—Anaphylactic shock—Methotrexate—hematologic cancer	4.06e-06	6.47e-05	CcSEcCtD
Fludarabine—Convulsion—Epirubicin—hematologic cancer	4.04e-06	6.43e-05	CcSEcCtD
Fludarabine—Infection—Methotrexate—hematologic cancer	4.04e-06	6.43e-05	CcSEcCtD
Fludarabine—Nausea—Etoposide—hematologic cancer	4.03e-06	6.42e-05	CcSEcCtD
Fludarabine—Feeling abnormal—Prednisone—hematologic cancer	4.01e-06	6.38e-05	CcSEcCtD
Fludarabine—Asthenia—Dexamethasone—hematologic cancer	4.01e-06	6.38e-05	CcSEcCtD
Fludarabine—Asthenia—Betamethasone—hematologic cancer	4.01e-06	6.38e-05	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—CCND1—hematologic cancer	4e-06	0.000198	CbGpPWpGaD
Fludarabine—Ill-defined disorder—Doxorubicin—hematologic cancer	4e-06	6.37e-05	CcSEcCtD
Fludarabine—Nervous system disorder—Methotrexate—hematologic cancer	3.99e-06	6.35e-05	CcSEcCtD
Fludarabine—Anaemia—Doxorubicin—hematologic cancer	3.99e-06	6.35e-05	CcSEcCtD
Fludarabine—Thrombocytopenia—Methotrexate—hematologic cancer	3.98e-06	6.34e-05	CcSEcCtD
Fludarabine—Nausea—Prednisolone—hematologic cancer	3.98e-06	6.33e-05	CcSEcCtD
Fludarabine—Myalgia—Epirubicin—hematologic cancer	3.97e-06	6.32e-05	CcSEcCtD
Fludarabine—Arthralgia—Epirubicin—hematologic cancer	3.97e-06	6.32e-05	CcSEcCtD
Fludarabine—Agitation—Doxorubicin—hematologic cancer	3.96e-06	6.31e-05	CcSEcCtD
Fludarabine—Pruritus—Betamethasone—hematologic cancer	3.95e-06	6.29e-05	CcSEcCtD
Fludarabine—Pruritus—Dexamethasone—hematologic cancer	3.95e-06	6.29e-05	CcSEcCtD
Fludarabine—Hyperhidrosis—Methotrexate—hematologic cancer	3.93e-06	6.26e-05	CcSEcCtD
Fludarabine—Discomfort—Epirubicin—hematologic cancer	3.92e-06	6.25e-05	CcSEcCtD
Fludarabine—Vomiting—Triamcinolone—hematologic cancer	3.91e-06	6.23e-05	CcSEcCtD
Fludarabine—RRM1—Metabolism—PIK3CD—hematologic cancer	3.91e-06	0.000193	CbGpPWpGaD
Fludarabine—Malaise—Doxorubicin—hematologic cancer	3.89e-06	6.2e-05	CcSEcCtD
Fludarabine—Rash—Triamcinolone—hematologic cancer	3.88e-06	6.18e-05	CcSEcCtD
Fludarabine—Dermatitis—Triamcinolone—hematologic cancer	3.88e-06	6.18e-05	CcSEcCtD
Fludarabine—Anorexia—Methotrexate—hematologic cancer	3.87e-06	6.17e-05	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—CDKN1A—hematologic cancer	3.87e-06	0.000191	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ALB—hematologic cancer	3.86e-06	0.000191	CbGpPWpGaD
Fludarabine—Leukopenia—Doxorubicin—hematologic cancer	3.86e-06	6.15e-05	CcSEcCtD
Fludarabine—Headache—Triamcinolone—hematologic cancer	3.86e-06	6.14e-05	CcSEcCtD
Fludarabine—Body temperature increased—Prednisone—hematologic cancer	3.84e-06	6.12e-05	CcSEcCtD
Fludarabine—Confusional state—Epirubicin—hematologic cancer	3.84e-06	6.11e-05	CcSEcCtD
Fludarabine—Diarrhoea—Dexamethasone—hematologic cancer	3.82e-06	6.09e-05	CcSEcCtD
Fludarabine—Diarrhoea—Betamethasone—hematologic cancer	3.82e-06	6.09e-05	CcSEcCtD
Fludarabine—Anaphylactic shock—Epirubicin—hematologic cancer	3.8e-06	6.06e-05	CcSEcCtD
Fludarabine—Oedema—Epirubicin—hematologic cancer	3.8e-06	6.06e-05	CcSEcCtD
Fludarabine—Infection—Epirubicin—hematologic cancer	3.78e-06	6.02e-05	CcSEcCtD
Fludarabine—Cough—Doxorubicin—hematologic cancer	3.76e-06	5.99e-05	CcSEcCtD
Fludarabine—Convulsion—Doxorubicin—hematologic cancer	3.74e-06	5.95e-05	CcSEcCtD
Fludarabine—Nervous system disorder—Epirubicin—hematologic cancer	3.73e-06	5.94e-05	CcSEcCtD
Fludarabine—Thrombocytopenia—Epirubicin—hematologic cancer	3.72e-06	5.93e-05	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.7e-06	5.9e-05	CcSEcCtD
Fludarabine—RRM1—Metabolism—PIK3R1—hematologic cancer	3.69e-06	0.000183	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—MAPK3—hematologic cancer	3.69e-06	0.000183	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—EP300—hematologic cancer	3.68e-06	0.000182	CbGpPWpGaD
Fludarabine—Hyperhidrosis—Epirubicin—hematologic cancer	3.68e-06	5.86e-05	CcSEcCtD
Fludarabine—Arthralgia—Doxorubicin—hematologic cancer	3.67e-06	5.85e-05	CcSEcCtD
Fludarabine—Myalgia—Doxorubicin—hematologic cancer	3.67e-06	5.85e-05	CcSEcCtD
Fludarabine—Nausea—Triamcinolone—hematologic cancer	3.66e-06	5.82e-05	CcSEcCtD
Fludarabine—Paraesthesia—Methotrexate—hematologic cancer	3.65e-06	5.81e-05	CcSEcCtD
Fludarabine—Discomfort—Doxorubicin—hematologic cancer	3.63e-06	5.78e-05	CcSEcCtD
Fludarabine—Anorexia—Epirubicin—hematologic cancer	3.63e-06	5.78e-05	CcSEcCtD
Fludarabine—Dyspnoea—Methotrexate—hematologic cancer	3.62e-06	5.77e-05	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—MYC—hematologic cancer	3.59e-06	0.000178	CbGpPWpGaD
Fludarabine—Hypersensitivity—Prednisone—hematologic cancer	3.58e-06	5.71e-05	CcSEcCtD
Fludarabine—Dyspepsia—Methotrexate—hematologic cancer	3.58e-06	5.7e-05	CcSEcCtD
Fludarabine—Vomiting—Dexamethasone—hematologic cancer	3.55e-06	5.66e-05	CcSEcCtD
Fludarabine—Vomiting—Betamethasone—hematologic cancer	3.55e-06	5.66e-05	CcSEcCtD
Fludarabine—Confusional state—Doxorubicin—hematologic cancer	3.55e-06	5.65e-05	CcSEcCtD
Fludarabine—Decreased appetite—Methotrexate—hematologic cancer	3.53e-06	5.63e-05	CcSEcCtD
Fludarabine—Rash—Betamethasone—hematologic cancer	3.52e-06	5.61e-05	CcSEcCtD
Fludarabine—Rash—Dexamethasone—hematologic cancer	3.52e-06	5.61e-05	CcSEcCtD
Fludarabine—Anaphylactic shock—Doxorubicin—hematologic cancer	3.52e-06	5.61e-05	CcSEcCtD
Fludarabine—Oedema—Doxorubicin—hematologic cancer	3.52e-06	5.61e-05	CcSEcCtD
Fludarabine—Dermatitis—Betamethasone—hematologic cancer	3.52e-06	5.6e-05	CcSEcCtD
Fludarabine—Dermatitis—Dexamethasone—hematologic cancer	3.52e-06	5.6e-05	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.51e-06	5.59e-05	CcSEcCtD
Fludarabine—Fatigue—Methotrexate—hematologic cancer	3.5e-06	5.58e-05	CcSEcCtD
Fludarabine—Headache—Dexamethasone—hematologic cancer	3.5e-06	5.57e-05	CcSEcCtD
Fludarabine—Headache—Betamethasone—hematologic cancer	3.5e-06	5.57e-05	CcSEcCtD
Fludarabine—Infection—Doxorubicin—hematologic cancer	3.5e-06	5.57e-05	CcSEcCtD
Fludarabine—Asthenia—Prednisone—hematologic cancer	3.49e-06	5.56e-05	CcSEcCtD
Fludarabine—Pain—Methotrexate—hematologic cancer	3.48e-06	5.54e-05	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.47e-06	5.52e-05	CcSEcCtD
Fludarabine—Nervous system disorder—Doxorubicin—hematologic cancer	3.45e-06	5.5e-05	CcSEcCtD
Fludarabine—Thrombocytopenia—Doxorubicin—hematologic cancer	3.45e-06	5.49e-05	CcSEcCtD
Fludarabine—Pruritus—Prednisone—hematologic cancer	3.44e-06	5.48e-05	CcSEcCtD
Fludarabine—DCK—Metabolism—PIK3CG—hematologic cancer	3.42e-06	0.000169	CbGpPWpGaD
Fludarabine—Paraesthesia—Epirubicin—hematologic cancer	3.42e-06	5.44e-05	CcSEcCtD
Fludarabine—RRM1—Metabolism—PIK3CB—hematologic cancer	3.41e-06	0.000169	CbGpPWpGaD
Fludarabine—Hyperhidrosis—Doxorubicin—hematologic cancer	3.4e-06	5.42e-05	CcSEcCtD
Fludarabine—Dyspnoea—Epirubicin—hematologic cancer	3.39e-06	5.4e-05	CcSEcCtD
Fludarabine—Anorexia—Doxorubicin—hematologic cancer	3.35e-06	5.34e-05	CcSEcCtD
Fludarabine—Feeling abnormal—Methotrexate—hematologic cancer	3.35e-06	5.34e-05	CcSEcCtD
Fludarabine—Dyspepsia—Epirubicin—hematologic cancer	3.35e-06	5.33e-05	CcSEcCtD
Fludarabine—Diarrhoea—Prednisone—hematologic cancer	3.33e-06	5.3e-05	CcSEcCtD
Fludarabine—Nausea—Dexamethasone—hematologic cancer	3.32e-06	5.28e-05	CcSEcCtD
Fludarabine—Nausea—Betamethasone—hematologic cancer	3.32e-06	5.28e-05	CcSEcCtD
Fludarabine—Decreased appetite—Epirubicin—hematologic cancer	3.31e-06	5.27e-05	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—MAPK3—hematologic cancer	3.3e-06	0.000163	CbGpPWpGaD
Fludarabine—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.28e-06	5.23e-05	CcSEcCtD
Fludarabine—Fatigue—Epirubicin—hematologic cancer	3.28e-06	5.22e-05	CcSEcCtD
Fludarabine—Pain—Epirubicin—hematologic cancer	3.25e-06	5.18e-05	CcSEcCtD
Fludarabine—Constipation—Epirubicin—hematologic cancer	3.25e-06	5.18e-05	CcSEcCtD
Fludarabine—Body temperature increased—Methotrexate—hematologic cancer	3.21e-06	5.12e-05	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—MYC—hematologic cancer	3.21e-06	0.000159	CbGpPWpGaD
Fludarabine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.21e-06	5.11e-05	CcSEcCtD
Fludarabine—DCK—Metabolism—CREBBP—hematologic cancer	3.17e-06	0.000157	CbGpPWpGaD
Fludarabine—Paraesthesia—Doxorubicin—hematologic cancer	3.16e-06	5.03e-05	CcSEcCtD
Fludarabine—Dyspnoea—Doxorubicin—hematologic cancer	3.14e-06	5e-05	CcSEcCtD
Fludarabine—Feeling abnormal—Epirubicin—hematologic cancer	3.13e-06	4.99e-05	CcSEcCtD
Fludarabine—Dyspepsia—Doxorubicin—hematologic cancer	3.1e-06	4.94e-05	CcSEcCtD
Fludarabine—Vomiting—Prednisone—hematologic cancer	3.09e-06	4.93e-05	CcSEcCtD
Fludarabine—Rash—Prednisone—hematologic cancer	3.07e-06	4.88e-05	CcSEcCtD
Fludarabine—Dermatitis—Prednisone—hematologic cancer	3.06e-06	4.88e-05	CcSEcCtD
Fludarabine—Decreased appetite—Doxorubicin—hematologic cancer	3.06e-06	4.87e-05	CcSEcCtD
Fludarabine—Headache—Prednisone—hematologic cancer	3.05e-06	4.85e-05	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.04e-06	4.84e-05	CcSEcCtD
Fludarabine—Fatigue—Doxorubicin—hematologic cancer	3.03e-06	4.83e-05	CcSEcCtD
Fludarabine—DCK—Metabolism—PIK3CD—hematologic cancer	3.01e-06	0.000149	CbGpPWpGaD
Fludarabine—Pain—Doxorubicin—hematologic cancer	3.01e-06	4.79e-05	CcSEcCtD
Fludarabine—Constipation—Doxorubicin—hematologic cancer	3.01e-06	4.79e-05	CcSEcCtD
Fludarabine—Body temperature increased—Epirubicin—hematologic cancer	3.01e-06	4.79e-05	CcSEcCtD
Fludarabine—Hypersensitivity—Methotrexate—hematologic cancer	2.99e-06	4.77e-05	CcSEcCtD
Fludarabine—DCK—Metabolism—ALB—hematologic cancer	2.97e-06	0.000147	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PTEN—hematologic cancer	2.95e-06	0.000146	CbGpPWpGaD
Fludarabine—Asthenia—Methotrexate—hematologic cancer	2.92e-06	4.65e-05	CcSEcCtD
Fludarabine—Feeling abnormal—Doxorubicin—hematologic cancer	2.9e-06	4.62e-05	CcSEcCtD
Fludarabine—Nausea—Prednisone—hematologic cancer	2.89e-06	4.6e-05	CcSEcCtD
Fludarabine—Pruritus—Methotrexate—hematologic cancer	2.88e-06	4.58e-05	CcSEcCtD
Fludarabine—DCK—Metabolism—PIK3R1—hematologic cancer	2.84e-06	0.000141	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—EP300—hematologic cancer	2.81e-06	0.000139	CbGpPWpGaD
Fludarabine—Hypersensitivity—Epirubicin—hematologic cancer	2.8e-06	4.46e-05	CcSEcCtD
Fludarabine—Body temperature increased—Doxorubicin—hematologic cancer	2.78e-06	4.43e-05	CcSEcCtD
Fludarabine—Diarrhoea—Methotrexate—hematologic cancer	2.78e-06	4.43e-05	CcSEcCtD
Fludarabine—Asthenia—Epirubicin—hematologic cancer	2.73e-06	4.35e-05	CcSEcCtD
Fludarabine—Pruritus—Epirubicin—hematologic cancer	2.69e-06	4.29e-05	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—TP53—hematologic cancer	2.64e-06	0.00013	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CB—hematologic cancer	2.62e-06	0.00013	CbGpPWpGaD
Fludarabine—Diarrhoea—Epirubicin—hematologic cancer	2.6e-06	4.15e-05	CcSEcCtD
Fludarabine—Hypersensitivity—Doxorubicin—hematologic cancer	2.59e-06	4.13e-05	CcSEcCtD
Fludarabine—Vomiting—Methotrexate—hematologic cancer	2.58e-06	4.12e-05	CcSEcCtD
Fludarabine—Rash—Methotrexate—hematologic cancer	2.56e-06	4.08e-05	CcSEcCtD
Fludarabine—Dermatitis—Methotrexate—hematologic cancer	2.56e-06	4.08e-05	CcSEcCtD
Fludarabine—Headache—Methotrexate—hematologic cancer	2.55e-06	4.06e-05	CcSEcCtD
Fludarabine—Asthenia—Doxorubicin—hematologic cancer	2.53e-06	4.02e-05	CcSEcCtD
Fludarabine—Pruritus—Doxorubicin—hematologic cancer	2.49e-06	3.97e-05	CcSEcCtD
Fludarabine—Vomiting—Epirubicin—hematologic cancer	2.42e-06	3.85e-05	CcSEcCtD
Fludarabine—Nausea—Methotrexate—hematologic cancer	2.41e-06	3.85e-05	CcSEcCtD
Fludarabine—Diarrhoea—Doxorubicin—hematologic cancer	2.41e-06	3.84e-05	CcSEcCtD
Fludarabine—Rash—Epirubicin—hematologic cancer	2.4e-06	3.82e-05	CcSEcCtD
Fludarabine—Dermatitis—Epirubicin—hematologic cancer	2.4e-06	3.82e-05	CcSEcCtD
Fludarabine—Headache—Epirubicin—hematologic cancer	2.38e-06	3.8e-05	CcSEcCtD
Fludarabine—DCK—Metabolism—PTEN—hematologic cancer	2.27e-06	0.000112	CbGpPWpGaD
Fludarabine—Nausea—Epirubicin—hematologic cancer	2.26e-06	3.6e-05	CcSEcCtD
Fludarabine—Vomiting—Doxorubicin—hematologic cancer	2.24e-06	3.56e-05	CcSEcCtD
Fludarabine—Rash—Doxorubicin—hematologic cancer	2.22e-06	3.54e-05	CcSEcCtD
Fludarabine—Dermatitis—Doxorubicin—hematologic cancer	2.22e-06	3.53e-05	CcSEcCtD
Fludarabine—Headache—Doxorubicin—hematologic cancer	2.2e-06	3.51e-05	CcSEcCtD
Fludarabine—DCK—Metabolism—EP300—hematologic cancer	2.16e-06	0.000107	CbGpPWpGaD
Fludarabine—Nausea—Doxorubicin—hematologic cancer	2.09e-06	3.33e-05	CcSEcCtD
Fludarabine—RRM1—Metabolism—PIK3CA—hematologic cancer	2.08e-06	0.000103	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—AKT1—hematologic cancer	1.7e-06	8.4e-05	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CA—hematologic cancer	1.6e-06	7.91e-05	CbGpPWpGaD
Fludarabine—DCK—Metabolism—AKT1—hematologic cancer	1.31e-06	6.46e-05	CbGpPWpGaD
